Vladimir Zharov
Concepts (386)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Flow Cytometry | 42 | 2024 | 476 | 10.830 |
Why?
| Photoacoustic Techniques | 26 | 2024 | 72 | 8.720 |
Why?
| Neoplastic Cells, Circulating | 22 | 2021 | 74 | 5.860 |
Why?
| Molecular Imaging | 15 | 2021 | 53 | 4.580 |
Why?
| Gold | 29 | 2020 | 136 | 4.410 |
Why?
| Nanoparticles | 21 | 2020 | 145 | 4.170 |
Why?
| Lasers | 28 | 2021 | 123 | 3.870 |
Why?
| Nanotubes, Carbon | 15 | 2020 | 66 | 3.180 |
Why?
| Light | 13 | 2020 | 71 | 3.110 |
Why?
| Acoustics | 9 | 2016 | 33 | 2.710 |
Why?
| Contrast Media | 11 | 2017 | 184 | 2.500 |
Why?
| Nanotechnology | 8 | 2015 | 35 | 2.310 |
Why?
| Metal Nanoparticles | 12 | 2020 | 84 | 2.290 |
Why?
| Erythrocytes | 9 | 2024 | 83 | 2.190 |
Why?
| Animals | 69 | 2022 | 13187 | 2.060 |
Why?
| Microscopy | 10 | 2018 | 56 | 1.930 |
Why?
| Mice | 41 | 2022 | 5739 | 1.840 |
Why?
| Mesentery | 9 | 2011 | 32 | 1.830 |
Why?
| Temperature | 11 | 2016 | 168 | 1.830 |
Why?
| Fluorescent Dyes | 8 | 2020 | 102 | 1.810 |
Why?
| Mice, Nude | 17 | 2018 | 252 | 1.810 |
Why?
| Phototherapy | 11 | 2019 | 45 | 1.700 |
Why?
| Microscopy, Fluorescence | 9 | 2019 | 162 | 1.640 |
Why?
| Lymphatic Vessels | 6 | 2019 | 48 | 1.600 |
Why?
| Melanoma | 5 | 2022 | 285 | 1.560 |
Why?
| Cell Line, Tumor | 26 | 2021 | 1403 | 1.520 |
Why?
| Image Cytometry | 4 | 2011 | 12 | 1.520 |
Why?
| Neoplasms | 16 | 2019 | 1235 | 1.420 |
Why?
| Thermography | 5 | 2009 | 11 | 1.400 |
Why?
| Malaria | 3 | 2024 | 37 | 1.380 |
Why?
| Spectrum Analysis, Raman | 10 | 2020 | 58 | 1.360 |
Why?
| Plasmodium yoelii | 2 | 2022 | 14 | 1.360 |
Why?
| Single-Cell Analysis | 4 | 2019 | 57 | 1.340 |
Why?
| Hot Temperature | 10 | 2013 | 207 | 1.320 |
Why?
| Melanoma, Experimental | 3 | 2016 | 45 | 1.240 |
Why?
| Magnetite Nanoparticles | 4 | 2019 | 21 | 1.240 |
Why?
| Drug Delivery Systems | 7 | 2019 | 138 | 1.230 |
Why?
| Cell Separation | 5 | 2008 | 89 | 1.160 |
Why?
| Nanostructures | 6 | 2019 | 47 | 1.110 |
Why?
| Lymph | 6 | 2019 | 19 | 1.090 |
Why?
| Blood Volume | 2 | 2019 | 68 | 1.060 |
Why?
| Staphylococcus aureus | 4 | 2019 | 326 | 1.060 |
Why?
| Skin | 5 | 2020 | 409 | 1.030 |
Why?
| Pharmaceutical Preparations | 2 | 2017 | 77 | 1.020 |
Why?
| Quantum Dots | 3 | 2017 | 12 | 1.010 |
Why?
| Laser Therapy | 4 | 2017 | 84 | 1.000 |
Why?
| Anemia, Sickle Cell | 3 | 2016 | 96 | 0.990 |
Why?
| Photometry | 5 | 2010 | 14 | 0.990 |
Why?
| Green Fluorescent Proteins | 3 | 2019 | 90 | 0.970 |
Why?
| Spectrum Analysis | 8 | 2016 | 70 | 0.960 |
Why?
| Breast Neoplasms | 7 | 2018 | 1174 | 0.950 |
Why?
| Ultrasonic Therapy | 3 | 2017 | 34 | 0.940 |
Why?
| Fluorescence | 5 | 2018 | 41 | 0.920 |
Why?
| Blood Vessels | 3 | 2019 | 72 | 0.920 |
Why?
| Humans | 66 | 2024 | 49974 | 0.910 |
Why?
| Microscopy, Confocal | 2 | 2015 | 88 | 0.910 |
Why?
| Staphylococcal Infections | 2 | 2019 | 268 | 0.900 |
Why?
| Rats | 17 | 2019 | 3305 | 0.870 |
Why?
| Disease Models, Animal | 6 | 2021 | 1455 | 0.860 |
Why?
| Models, Theoretical | 3 | 2017 | 175 | 0.800 |
Why?
| Plant Leaves | 2 | 2011 | 43 | 0.760 |
Why?
| Skin Neoplasms | 3 | 2011 | 488 | 0.750 |
Why?
| Drug Carriers | 3 | 2017 | 67 | 0.750 |
Why?
| Ultrasonography | 4 | 2020 | 436 | 0.740 |
Why?
| Photochemotherapy | 2 | 2017 | 34 | 0.740 |
Why?
| Graphite | 2 | 2019 | 28 | 0.730 |
Why?
| Apoptosis | 4 | 2018 | 1101 | 0.700 |
Why?
| Nicotine | 3 | 2005 | 187 | 0.690 |
Why?
| Protein Engineering | 1 | 2019 | 18 | 0.690 |
Why?
| Melanins | 5 | 2021 | 27 | 0.690 |
Why?
| Nanomedicine | 5 | 2017 | 21 | 0.690 |
Why?
| Diagnostic Imaging | 4 | 2017 | 176 | 0.660 |
Why?
| Nanocomposites | 1 | 2019 | 9 | 0.660 |
Why?
| Early Detection of Cancer | 4 | 2022 | 169 | 0.650 |
Why?
| Cardiovascular Diseases | 4 | 2021 | 440 | 0.650 |
Why?
| Silicon Dioxide | 2 | 2020 | 15 | 0.640 |
Why?
| Models, Biological | 3 | 2009 | 727 | 0.620 |
Why?
| Blood Circulation | 3 | 2021 | 15 | 0.610 |
Why?
| Hemeproteins | 2 | 2024 | 8 | 0.610 |
Why?
| Parasitemia | 2 | 2024 | 8 | 0.610 |
Why?
| Hemorheology | 3 | 2011 | 11 | 0.600 |
Why?
| Image Interpretation, Computer-Assisted | 6 | 2011 | 106 | 0.590 |
Why?
| Leukocytes | 3 | 2016 | 66 | 0.590 |
Why?
| Nanospheres | 2 | 2017 | 8 | 0.580 |
Why?
| Luminescent Proteins | 2 | 2014 | 53 | 0.570 |
Why?
| Molecular Probes | 1 | 2016 | 9 | 0.570 |
Why?
| Nanotubes | 7 | 2020 | 27 | 0.570 |
Why?
| Pancreatic Neoplasms | 3 | 2020 | 208 | 0.560 |
Why?
| Lasers, Semiconductor | 2 | 2022 | 10 | 0.560 |
Why?
| Image Enhancement | 2 | 2006 | 54 | 0.560 |
Why?
| Antineoplastic Agents | 4 | 2017 | 1171 | 0.550 |
Why?
| Lasers, Solid-State | 1 | 2017 | 32 | 0.550 |
Why?
| Cell Survival | 8 | 2018 | 600 | 0.550 |
Why?
| Embolism | 1 | 2016 | 20 | 0.550 |
Why?
| Imaging, Three-Dimensional | 3 | 2012 | 151 | 0.540 |
Why?
| Escherichia coli | 2 | 2007 | 186 | 0.540 |
Why?
| Exosomes | 1 | 2016 | 49 | 0.540 |
Why?
| Lymphatic Metastasis | 4 | 2020 | 224 | 0.540 |
Why?
| Magnetics | 3 | 2011 | 39 | 0.520 |
Why?
| Laser Scanning Cytometry | 3 | 2010 | 8 | 0.510 |
Why?
| Staining and Labeling | 3 | 2013 | 97 | 0.490 |
Why?
| Blood Cells | 4 | 2012 | 43 | 0.490 |
Why?
| Plant Roots | 2 | 2011 | 34 | 0.470 |
Why?
| Optical Phenomena | 2 | 2017 | 11 | 0.460 |
Why?
| Signal Processing, Computer-Assisted | 3 | 2011 | 70 | 0.460 |
Why?
| Neoplastic Stem Cells | 3 | 2020 | 103 | 0.460 |
Why?
| Hyperthermia, Induced | 4 | 2019 | 117 | 0.460 |
Why?
| Blood Flow Velocity | 2 | 2011 | 101 | 0.460 |
Why?
| Infrared Rays | 3 | 2016 | 25 | 0.460 |
Why?
| Blood Coagulation | 2 | 2011 | 56 | 0.460 |
Why?
| Neoplasm Proteins | 2 | 2006 | 322 | 0.450 |
Why?
| Neoplasm Metastasis | 2 | 2015 | 231 | 0.450 |
Why?
| Lymph Nodes | 3 | 2020 | 260 | 0.440 |
Why?
| Mosquito Control | 1 | 2013 | 4 | 0.440 |
Why?
| Aedes | 1 | 2013 | 12 | 0.440 |
Why?
| Microscopy, Electron, Transmission | 5 | 2017 | 75 | 0.440 |
Why?
| Rats, Sprague-Dawley | 7 | 2019 | 1597 | 0.440 |
Why?
| Scattering, Radiation | 3 | 2009 | 31 | 0.420 |
Why?
| Early Diagnosis | 4 | 2016 | 88 | 0.420 |
Why?
| Reproducibility of Results | 6 | 2021 | 1193 | 0.420 |
Why?
| Models, Animal | 3 | 2010 | 233 | 0.410 |
Why?
| Drug Evaluation, Preclinical | 2 | 2017 | 144 | 0.410 |
Why?
| Equipment Design | 6 | 2017 | 284 | 0.410 |
Why?
| Carotenoids | 1 | 2012 | 49 | 0.410 |
Why?
| Silver | 3 | 2017 | 46 | 0.400 |
Why?
| Xylem | 1 | 2011 | 3 | 0.400 |
Why?
| Phloem | 1 | 2011 | 3 | 0.400 |
Why?
| Bacteremia | 1 | 2012 | 90 | 0.390 |
Why?
| KB Cells | 1 | 2010 | 5 | 0.380 |
Why?
| Cytochromes c | 1 | 2010 | 29 | 0.380 |
Why?
| Thromboembolism | 1 | 2011 | 54 | 0.370 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2013 | 388 | 0.370 |
Why?
| Gene Expression Regulation, Plant | 1 | 2010 | 44 | 0.370 |
Why?
| Optics and Photonics | 2 | 2018 | 12 | 0.370 |
Why?
| Time Factors | 7 | 2018 | 2903 | 0.360 |
Why?
| Microscopy, Video | 2 | 2006 | 13 | 0.350 |
Why?
| Etoposide | 1 | 2009 | 72 | 0.350 |
Why?
| Cells | 1 | 2009 | 3 | 0.350 |
Why?
| Spectrophotometry, Infrared | 1 | 2009 | 8 | 0.330 |
Why?
| Color | 3 | 2016 | 22 | 0.330 |
Why?
| Blood Chemical Analysis | 1 | 2009 | 27 | 0.330 |
Why?
| Adipocytes | 1 | 2010 | 121 | 0.330 |
Why?
| Microscopy, Acoustic | 1 | 2008 | 5 | 0.330 |
Why?
| Capillaries | 2 | 2007 | 50 | 0.320 |
Why?
| Photochemistry | 4 | 2010 | 15 | 0.320 |
Why?
| Receptors, Cell Surface | 3 | 2019 | 122 | 0.320 |
Why?
| Image Processing, Computer-Assisted | 3 | 2018 | 242 | 0.310 |
Why?
| Cell Culture Techniques | 2 | 2005 | 99 | 0.310 |
Why?
| Antibodies | 4 | 2014 | 154 | 0.310 |
Why?
| Lenses | 1 | 2007 | 5 | 0.300 |
Why?
| Cell Count | 3 | 2019 | 147 | 0.300 |
Why?
| Colony Count, Microbial | 1 | 2007 | 66 | 0.300 |
Why?
| Myocardial Infarction | 1 | 2011 | 389 | 0.300 |
Why?
| Escherichia coli Infections | 1 | 2007 | 31 | 0.290 |
Why?
| Ultrasonics | 2 | 2016 | 29 | 0.290 |
Why?
| Mitochondria | 1 | 2010 | 402 | 0.290 |
Why?
| Spectrophotometry | 3 | 2016 | 33 | 0.290 |
Why?
| Flow Injection Analysis | 1 | 2006 | 2 | 0.290 |
Why?
| Vinblastine | 1 | 2006 | 23 | 0.280 |
Why?
| Lymphocytes | 2 | 2005 | 152 | 0.280 |
Why?
| Doxorubicin | 2 | 2019 | 233 | 0.280 |
Why?
| Particle Size | 3 | 2013 | 76 | 0.280 |
Why?
| Lymphedema | 1 | 2007 | 43 | 0.280 |
Why?
| Mesenteric Arteries | 1 | 2006 | 45 | 0.270 |
Why?
| Sensitivity and Specificity | 5 | 2024 | 861 | 0.270 |
Why?
| Plasmodium falciparum | 2 | 2024 | 18 | 0.270 |
Why?
| Stroke | 1 | 2011 | 492 | 0.270 |
Why?
| Neoplasm Recurrence, Local | 4 | 2021 | 614 | 0.270 |
Why?
| Cell Line | 6 | 2019 | 1000 | 0.260 |
Why?
| Nicotinic Agonists | 1 | 2005 | 56 | 0.260 |
Why?
| Antibodies, Neoplasm | 1 | 2005 | 28 | 0.260 |
Why?
| Indocyanine Green | 2 | 2019 | 34 | 0.260 |
Why?
| Carcinoma | 1 | 2006 | 138 | 0.250 |
Why?
| Pancreas | 1 | 2005 | 70 | 0.250 |
Why?
| K562 Cells | 1 | 2005 | 42 | 0.250 |
Why?
| Anti-Bacterial Agents | 3 | 2019 | 744 | 0.250 |
Why?
| Microcirculation | 1 | 2005 | 70 | 0.250 |
Why?
| Injections, Intravenous | 2 | 2017 | 140 | 0.240 |
Why?
| Lymphatic System | 2 | 2018 | 14 | 0.230 |
Why?
| Diffusion | 2 | 2017 | 15 | 0.230 |
Why?
| Systems Integration | 4 | 2007 | 22 | 0.220 |
Why?
| Folic Acid | 2 | 2017 | 135 | 0.220 |
Why?
| Materials Testing | 2 | 2017 | 58 | 0.210 |
Why?
| Mice, Inbred C57BL | 3 | 2019 | 1816 | 0.210 |
Why?
| Carcinoma, Hepatocellular | 2 | 2021 | 191 | 0.210 |
Why?
| Combined Modality Therapy | 3 | 2017 | 637 | 0.200 |
Why?
| Mice, Transgenic | 2 | 2016 | 555 | 0.200 |
Why?
| Huntington Disease | 1 | 2021 | 23 | 0.200 |
Why?
| Adenocarcinoma | 1 | 2005 | 396 | 0.190 |
Why?
| Pharmacokinetics | 2 | 2017 | 16 | 0.190 |
Why?
| Administration, Cutaneous | 2 | 2017 | 51 | 0.190 |
Why?
| Rheology | 2 | 2011 | 7 | 0.190 |
Why?
| Dose-Response Relationship, Drug | 4 | 2019 | 1376 | 0.180 |
Why?
| Phantoms, Imaging | 2 | 2011 | 121 | 0.180 |
Why?
| HeLa Cells | 3 | 2009 | 250 | 0.180 |
Why?
| Surgical Wound Infection | 1 | 2001 | 115 | 0.170 |
Why?
| Female | 9 | 2024 | 26472 | 0.170 |
Why?
| Stromal Cells | 1 | 2020 | 72 | 0.170 |
Why?
| Sentinel Lymph Node Biopsy | 1 | 2020 | 116 | 0.170 |
Why?
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 13 | 0.170 |
Why?
| Phagocytosis | 2 | 2017 | 48 | 0.170 |
Why?
| Muscle Cells | 1 | 2019 | 22 | 0.170 |
Why?
| Pseudomonas aeruginosa | 1 | 2019 | 72 | 0.170 |
Why?
| Tomography, Optical Coherence | 1 | 2020 | 100 | 0.170 |
Why?
| Staurosporine | 1 | 2018 | 12 | 0.160 |
Why?
| Meningeal Neoplasms | 1 | 2019 | 51 | 0.160 |
Why?
| Muscle Contraction | 1 | 2019 | 105 | 0.160 |
Why?
| Kinetics | 2 | 2011 | 623 | 0.160 |
Why?
| Diagnostic Techniques and Procedures | 1 | 2018 | 6 | 0.160 |
Why?
| Therapeutics | 1 | 2018 | 5 | 0.160 |
Why?
| Administration, Topical | 1 | 1998 | 56 | 0.160 |
Why?
| Quaternary Ammonium Compounds | 1 | 1998 | 29 | 0.160 |
Why?
| Computer Systems | 2 | 2009 | 21 | 0.160 |
Why?
| Ultrasonography, Interventional | 2 | 2017 | 136 | 0.150 |
Why?
| Microscopy, Phase-Contrast | 2 | 2009 | 11 | 0.150 |
Why?
| Endothelium, Lymphatic | 2 | 2009 | 12 | 0.150 |
Why?
| Tumor Cells, Cultured | 2 | 2009 | 465 | 0.150 |
Why?
| Lymphatic Abnormalities | 1 | 2017 | 22 | 0.150 |
Why?
| Histocompatibility Antigens Class II | 1 | 2017 | 37 | 0.150 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 36 | 0.150 |
Why?
| Bacterial Infections | 1 | 2018 | 95 | 0.150 |
Why?
| Galectin 1 | 1 | 2017 | 21 | 0.140 |
Why?
| Liver Neoplasms | 1 | 2021 | 326 | 0.140 |
Why?
| Cells, Cultured | 3 | 2007 | 1573 | 0.140 |
Why?
| Polyethylene Glycols | 1 | 2017 | 93 | 0.140 |
Why?
| Male | 8 | 2024 | 25241 | 0.140 |
Why?
| Hemoglobin, Sickle | 1 | 2016 | 6 | 0.140 |
Why?
| Biocompatible Materials | 1 | 2017 | 69 | 0.140 |
Why?
| Nonlinear Dynamics | 1 | 2016 | 19 | 0.140 |
Why?
| Caenorhabditis elegans | 2 | 2021 | 138 | 0.140 |
Why?
| Schizonts | 1 | 2016 | 3 | 0.140 |
Why?
| Dendritic Cells | 1 | 2017 | 133 | 0.140 |
Why?
| Photochemical Processes | 2 | 2014 | 9 | 0.140 |
Why?
| Ear | 1 | 2016 | 17 | 0.140 |
Why?
| Ampicillin | 1 | 2016 | 6 | 0.140 |
Why?
| Host-Parasite Interactions | 1 | 2016 | 16 | 0.140 |
Why?
| Equipment Failure Analysis | 2 | 2006 | 46 | 0.140 |
Why?
| Transducers | 1 | 2016 | 20 | 0.140 |
Why?
| Computers, Handheld | 1 | 2016 | 25 | 0.130 |
Why?
| Genes, Reporter | 1 | 2016 | 89 | 0.130 |
Why?
| Surface Plasmon Resonance | 3 | 2017 | 22 | 0.130 |
Why?
| Brain Neoplasms | 1 | 2019 | 287 | 0.130 |
Why?
| Drug Compounding | 1 | 2015 | 24 | 0.130 |
Why?
| Workflow | 1 | 2015 | 51 | 0.130 |
Why?
| Mammography | 1 | 2015 | 96 | 0.120 |
Why?
| Biological Transport | 1 | 2015 | 174 | 0.120 |
Why?
| Blood Platelets | 2 | 2021 | 245 | 0.120 |
Why?
| Necrosis | 2 | 2005 | 176 | 0.120 |
Why?
| Cell Tracking | 1 | 2014 | 2 | 0.120 |
Why?
| Magnetic Phenomena | 1 | 2013 | 6 | 0.120 |
Why?
| Neoplasm Staging | 1 | 2016 | 740 | 0.120 |
Why?
| Algorithms | 2 | 2010 | 615 | 0.110 |
Why?
| Biopsy | 1 | 2015 | 584 | 0.110 |
Why?
| Cerebrospinal Fluid | 1 | 2013 | 32 | 0.110 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.110 |
Why?
| Complementary Therapies | 1 | 2012 | 25 | 0.110 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2013 | 184 | 0.110 |
Why?
| Lipoproteins | 1 | 2012 | 39 | 0.110 |
Why?
| Intracellular Space | 1 | 2012 | 25 | 0.100 |
Why?
| Radiation Dosage | 1 | 2013 | 157 | 0.100 |
Why?
| Gentian Violet | 1 | 2011 | 4 | 0.100 |
Why?
| Optical Fibers | 1 | 2011 | 7 | 0.100 |
Why?
| Trypan Blue | 1 | 2011 | 6 | 0.100 |
Why?
| Erythrocyte Deformability | 1 | 2011 | 2 | 0.100 |
Why?
| Erythrocyte Aggregation | 1 | 2011 | 3 | 0.100 |
Why?
| Blood Viscosity | 1 | 2011 | 4 | 0.100 |
Why?
| Succinimides | 1 | 2011 | 7 | 0.100 |
Why?
| Fluoresceins | 1 | 2011 | 11 | 0.100 |
Why?
| Arterioles | 1 | 2011 | 33 | 0.100 |
Why?
| Hematologic Tests | 1 | 2011 | 10 | 0.100 |
Why?
| Methylene Blue | 1 | 2011 | 10 | 0.100 |
Why?
| Hematocrit | 1 | 2011 | 44 | 0.100 |
Why?
| Splanchnic Circulation | 1 | 2011 | 40 | 0.100 |
Why?
| Bacteria | 1 | 2013 | 224 | 0.100 |
Why?
| Platelet Aggregation | 1 | 2011 | 71 | 0.100 |
Why?
| Carotid Arteries | 1 | 2011 | 85 | 0.100 |
Why?
| Aquaporin 2 | 1 | 2010 | 5 | 0.100 |
Why?
| Blood Loss, Surgical | 1 | 2011 | 72 | 0.100 |
Why?
| Hemoglobins | 1 | 2011 | 107 | 0.090 |
Why?
| Biopsy, Needle | 1 | 2011 | 183 | 0.090 |
Why?
| Mastectomy, Segmental | 1 | 2011 | 92 | 0.090 |
Why?
| Microarray Analysis | 1 | 2010 | 73 | 0.090 |
Why?
| Immunoconjugates | 1 | 2011 | 38 | 0.090 |
Why?
| Neoplasm Transplantation | 1 | 2010 | 85 | 0.090 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2011 | 89 | 0.090 |
Why?
| Spectroscopy, Near-Infrared | 1 | 2010 | 53 | 0.090 |
Why?
| Chylomicrons | 1 | 2010 | 4 | 0.090 |
Why?
| Oscillometry | 1 | 2010 | 8 | 0.090 |
Why?
| Survival Rate | 1 | 2013 | 894 | 0.090 |
Why?
| Neovascularization, Pathologic | 1 | 2011 | 161 | 0.090 |
Why?
| Plant Oils | 1 | 2010 | 16 | 0.090 |
Why?
| Water | 1 | 2010 | 77 | 0.090 |
Why?
| Folate Receptors, GPI-Anchored | 1 | 2009 | 7 | 0.090 |
Why?
| Ablation Techniques | 1 | 2009 | 20 | 0.090 |
Why?
| Catheter Ablation | 1 | 2011 | 123 | 0.090 |
Why?
| Lymphography | 1 | 2009 | 9 | 0.090 |
Why?
| Molecular Mimicry | 1 | 2009 | 38 | 0.090 |
Why?
| Extracellular Space | 1 | 2009 | 38 | 0.090 |
Why?
| Polymerase Chain Reaction | 1 | 2010 | 453 | 0.090 |
Why?
| Drug Synergism | 1 | 2009 | 150 | 0.080 |
Why?
| Feasibility Studies | 2 | 2011 | 375 | 0.080 |
Why?
| Cytoplasm | 1 | 2009 | 90 | 0.080 |
Why?
| Cell Death | 1 | 2009 | 181 | 0.080 |
Why?
| Genetic Therapy | 2 | 2006 | 114 | 0.080 |
Why?
| Mice, Inbred BALB C | 2 | 2021 | 304 | 0.080 |
Why?
| Swine | 2 | 2001 | 393 | 0.080 |
Why?
| Neoplasms, Experimental | 1 | 2008 | 114 | 0.080 |
Why?
| Carrier Proteins | 1 | 2009 | 304 | 0.080 |
Why?
| Refractometry | 1 | 2007 | 5 | 0.080 |
Why?
| Blood Coagulation Tests | 1 | 2007 | 19 | 0.070 |
Why?
| Magnetic Resonance Imaging | 2 | 2011 | 1537 | 0.070 |
Why?
| Oxidative Stress | 1 | 2012 | 770 | 0.070 |
Why?
| Molecular Conformation | 1 | 2006 | 67 | 0.070 |
Why?
| Virology | 1 | 2006 | 6 | 0.070 |
Why?
| Young Adult | 3 | 2024 | 3958 | 0.070 |
Why?
| Adenoviridae | 1 | 2006 | 51 | 0.070 |
Why?
| Microscopy, Electron | 1 | 2005 | 77 | 0.070 |
Why?
| Genetic Vectors | 1 | 2006 | 125 | 0.060 |
Why?
| Metals | 1 | 2005 | 34 | 0.060 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 828 | 0.060 |
Why?
| Metabolic Clearance Rate | 1 | 2005 | 68 | 0.060 |
Why?
| Rats, Inbred F344 | 1 | 2005 | 196 | 0.060 |
Why?
| Microspectrophotometry | 1 | 2005 | 1 | 0.060 |
Why?
| Protein Transport | 1 | 2005 | 180 | 0.060 |
Why?
| Cameroon | 1 | 2024 | 4 | 0.060 |
Why?
| Cluster Analysis | 1 | 2005 | 235 | 0.060 |
Why?
| Video Recording | 1 | 2005 | 79 | 0.060 |
Why?
| Malaria, Falciparum | 1 | 2024 | 13 | 0.060 |
Why?
| Computer Simulation | 1 | 2005 | 280 | 0.060 |
Why?
| ROC Curve | 1 | 2024 | 232 | 0.060 |
Why?
| Forearm | 1 | 2004 | 31 | 0.060 |
Why?
| Varicose Veins | 1 | 2004 | 19 | 0.060 |
Why?
| Veins | 1 | 2004 | 71 | 0.060 |
Why?
| Photobiology | 1 | 2002 | 2 | 0.050 |
Why?
| Biophysics | 1 | 2002 | 16 | 0.050 |
Why?
| Biophysical Phenomena | 1 | 2002 | 19 | 0.050 |
Why?
| Longitudinal Studies | 1 | 2024 | 688 | 0.050 |
Why?
| Liposomes | 1 | 2002 | 48 | 0.050 |
Why?
| Prognosis | 2 | 2021 | 1942 | 0.050 |
Why?
| Microwaves | 1 | 2021 | 11 | 0.050 |
Why?
| Injections, Jet | 1 | 2001 | 1 | 0.050 |
Why?
| Phonophoresis | 1 | 2001 | 1 | 0.050 |
Why?
| Iontophoresis | 1 | 2001 | 14 | 0.050 |
Why?
| Chemoembolization, Therapeutic | 1 | 2021 | 12 | 0.050 |
Why?
| Macrophage Activation | 1 | 2001 | 25 | 0.050 |
Why?
| Reference Standards | 1 | 2021 | 56 | 0.050 |
Why?
| Microspheres | 1 | 2020 | 25 | 0.050 |
Why?
| Photosensitizing Agents | 1 | 2001 | 21 | 0.050 |
Why?
| Recombinant Fusion Proteins | 1 | 2021 | 181 | 0.050 |
Why?
| Anti-Infective Agents, Local | 1 | 2001 | 25 | 0.050 |
Why?
| Middle Aged | 3 | 2024 | 12069 | 0.050 |
Why?
| Gram-Negative Bacteria | 1 | 2001 | 34 | 0.050 |
Why?
| Peptides | 1 | 2021 | 223 | 0.050 |
Why?
| Pancreatic Stellate Cells | 1 | 2020 | 2 | 0.050 |
Why?
| Spheroids, Cellular | 1 | 2020 | 25 | 0.040 |
Why?
| Optical Imaging | 1 | 2020 | 25 | 0.040 |
Why?
| Rabbits | 1 | 2001 | 370 | 0.040 |
Why?
| Adult | 3 | 2024 | 13236 | 0.040 |
Why?
| Burns | 1 | 2002 | 162 | 0.040 |
Why?
| Organ Culture Techniques | 1 | 2019 | 48 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2024 | 1557 | 0.040 |
Why?
| Quartz Crystal Microbalance Techniques | 1 | 2019 | 2 | 0.040 |
Why?
| Solutions | 1 | 1998 | 25 | 0.040 |
Why?
| Antibiotics, Antineoplastic | 1 | 2019 | 78 | 0.040 |
Why?
| Injections, Subcutaneous | 1 | 1998 | 54 | 0.040 |
Why?
| Coloring Agents | 1 | 1998 | 69 | 0.040 |
Why?
| Treatment Outcome | 1 | 2009 | 5141 | 0.040 |
Why?
| Tumor Microenvironment | 1 | 2020 | 212 | 0.040 |
Why?
| Adolescent | 2 | 2024 | 6356 | 0.040 |
Why?
| Wounds and Injuries | 1 | 2001 | 276 | 0.040 |
Why?
| Coated Materials, Biocompatible | 1 | 2017 | 33 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 119 | 0.030 |
Why?
| Biofilms | 1 | 2018 | 181 | 0.030 |
Why?
| Cell Differentiation | 1 | 2017 | 651 | 0.030 |
Why?
| MCF-7 Cells | 1 | 2014 | 68 | 0.030 |
Why?
| Aged | 2 | 2021 | 9310 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 459 | 0.030 |
Why?
| Cell Proliferation | 1 | 2017 | 1007 | 0.030 |
Why?
| Macrophages | 1 | 2016 | 363 | 0.030 |
Why?
| Mammary Neoplasms, Animal | 1 | 2013 | 35 | 0.030 |
Why?
| Vacuum | 1 | 2011 | 13 | 0.030 |
Why?
| Pilot Projects | 1 | 2011 | 699 | 0.020 |
Why?
| Gene Targeting | 1 | 2006 | 29 | 0.020 |
Why?
| Binding Sites | 1 | 2006 | 374 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2011 | 3129 | 0.010 |
Why?
| Risk Factors | 1 | 2011 | 3613 | 0.010 |
Why?
|
|
Zharov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|